Paper20006312
Innate and adaptive immune responses to human Mycobacterium tuberculosis infection.
Vankayalapati R and 1 other. Tuberculosis (Edinb), 2009. Cited by 31 papers, by iCite.
Cite this record
ConductScience Library. Innate and adaptive immune responses to human Mycobacterium tuberculosis infection. Papers, record 20006312. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20006312
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adaptive Immunity | Major topic |
| Antitubercular Agents | Major topic |
| Immunity, Innate | Major topic |
| Killer Cells, Natural | Major topic |
| Mycobacterium tuberculosis | Major topic |
| T-Lymphocytes, Regulatory | Major topic |
| Tuberculosis, Multidrug-Resistant | Major topic |
| Humans | |
| Immunotherapy |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| A1063514 | PHS HHS | United States | PubMed | PubMed | |
| AI054629 | NIAID NIH HHS | United States | R01AI054629 | PubMed and NIH | NIH RePORTER |
| AI073612 | NIAID NIH HHS | United States | R21AI073612 | PubMed and NIH | NIH RePORTER |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38204892 | Pulmonary tuberculosis and diabetes mellitus: Epidemiology, pathogenesis and therapeutic management (Review). | Med Int (Lond) | 2024 | https://conductscience.org/library/papers/38204892 | PubMed |
| 37887757 | Natural Killer Repertoire Restoration in TB/HIV Co-Infected Individuals Experienced an Immune Reconstitution Syndrome (CAMELIA Trial, ANRS 12153). | Pathogens | 2023 | https://conductscience.org/library/papers/37887757 | PubMed |
| 37221438 | Clinical manifestations and immune response to tuberculosis. | World J Microbiol Biotechnol | 2023 | https://conductscience.org/library/papers/37221438 | PubMed |
| 37101462 | Attenuated Cytokine-Induced Memory-Like Natural Killer Cell Responses to Mycobacterium tuberculosis in Tuberculosis Patients. | Infect Drug Resist | 2023 | https://conductscience.org/library/papers/37101462 | PubMed |
| 36359526 | Immunological Interactions between Intestinal Helminth Infections and Tuberculosis. | Diagnostics (Basel) | 2022 | https://conductscience.org/library/papers/36359526 | PubMed |
| 34415976 | Luteolin as a potential host-directed immunotherapy adjunct to isoniazid treatment of tuberculosis. | PLoS Pathog | 2021 | https://conductscience.org/library/papers/34415976 | PubMed |
| 33258733 | Systematic review and meta-analytic findings on the association between killer-cell immunoglobulin-like receptor genes and susceptibility to pulmonary tuberculosis. | Pathog Glob Health | 2021 | https://conductscience.org/library/papers/33258733 | PubMed |
| 32872175 | Diagnosis of Osteoarticular Tuberculosis: Perceptions, Protocols, Practices, and Priorities in the Endemic and Non-Endemic Areas of the World-A WAIOT View. | Microorganisms | 2020 | https://conductscience.org/library/papers/32872175 | PubMed |
| 29770360 | Biomarkers Associated with Death After Initiating Treatment for Tuberculosis and HIV in Patients with Very Low CD4 Cells. | Pathog Immun | 2018 | https://conductscience.org/library/papers/29770360 | PubMed |
| 28855906 | Memory of Natural Killer Cells: A New Chance against Mycobacterium tuberculosis? | Front Immunol | 2017 | https://conductscience.org/library/papers/28855906 | PubMed |
| 28543817 | Influence of diabetes mellitus on immunity to human tuberculosis. | Immunology | 2017 | https://conductscience.org/library/papers/28543817 | PubMed |
| 26831422 | Constitutive expression of SMAR1 confers susceptibility to Mycobacterium tuberculosis infection in a transgenic mouse model. | Indian J Med Res | 2015 | https://conductscience.org/library/papers/26831422 | PubMed |
| 26135005 | The innate immune response in human tuberculosis. | Cell Microbiol | 2015 | https://conductscience.org/library/papers/26135005 | PubMed |
| 25363329 | Type 2 diabetes mellitus is associated with altered CD8(+) T and natural killer cell function in pulmonary tuberculosis. | Immunology | 2015 | https://conductscience.org/library/papers/25363329 | PubMed |
| 24484408 | Serum complement C4b, fibronectin, and prolidase are associated with the pathological changes of pulmonary tuberculosis. | BMC Infect Dis | 2014 | https://conductscience.org/library/papers/24484408 | PubMed |
| 24098583 | The contribution of non-conventional T cells and NK cells in the mycobacterial-specific IFNγ response in Bacille Calmette-Guérin (BCG)-immunized infants. | PLoS One | 2013 | https://conductscience.org/library/papers/24098583 | PubMed |
| 23437083 | Bayesian approach to model CD137 signaling in human M. tuberculosis in vitro responses. | PLoS One | 2013 | https://conductscience.org/library/papers/23437083 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20006312
GET https://conductscience.org/api/papers/v1/20006312/authors